Vanda Pharmaceuticals Inc. Insider Trading for March 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vanda Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Vanda Pharmaceuticals Inc. for March 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Polymeropoulos Mihael Hristos | President and CEO | Option Exercise | M | 0.00 | 12,500 | 0 | 37,500 | |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Polymeropoulos Mihael Hristos | President and CEO | Option Exercise | M | 0.00 | 6,250 | 0 | 12,500 | |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Polymeropoulos Mihael Hristos | President and CEO | Option Exercise | M | 0.00 | 12,500 | 0 | 12,500 | |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Polymeropoulos Mihael Hristos | President and CEO | Option Exercise | M | 0.00 | 12,500 | 0 | 0 | |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Polymeropoulos Mihael Hristos | President and CEO | Sell | S | 10.53 | 21,900 | 230,607 | 548,921 | 570.8 K to 548.9 K (-3.84 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Polymeropoulos Mihael Hristos | President and CEO | Buy | M | 0.00 | 12,500 | 0 | 570,821 | 558.3 K to 570.8 K (+2.24 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Polymeropoulos Mihael Hristos | President and CEO | Buy | M | 0.00 | 6,250 | 0 | 558,321 | 552.1 K to 558.3 K (+1.13 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Polymeropoulos Mihael Hristos | President and CEO | Buy | M | 0.00 | 12,500 | 0 | 552,071 | 539.6 K to 552.1 K (+2.32 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Polymeropoulos Mihael Hristos | President and CEO | Buy | M | 0.00 | 12,500 | 0 | 539,571 | 527.1 K to 539.6 K (+2.37 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | M | 0.00 | 2,344 | 0 | 4,688 | |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | M | 0.00 | 4,687 | 0 | 4,688 | |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | M | 0.00 | 12,500 | 0 | 0 | |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Sell | S | 10.53 | 12,450 | 131,099 | 53,304 | 65.8 K to 53.3 K (-18.93 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Buy | M | 0.00 | 5,000 | 0 | 65,754 | 60.8 K to 65.8 K (+8.23 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Buy | M | 0.00 | 2,344 | 0 | 60,754 | 58.4 K to 60.8 K (+4.01 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Buy | M | 0.00 | 4,687 | 0 | 58,410 | 53.7 K to 58.4 K (+8.72 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Buy | M | 0.00 | 12,500 | 0 | 53,723 | 41.2 K to 53.7 K (+30.32 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Baroldi Paolo | SVP & Chief Medical ... | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Baroldi Paolo | SVP & Chief Medical ... | Option Exercise | M | 0.00 | 12,500 | 0 | 25,000 | |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Baroldi Paolo | SVP & Chief Medical ... | Sell | S | 10.54 | 8,940 | 94,228 | 30,545 | 39.5 K to 30.5 K (-22.64 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Baroldi Paolo | SVP & Chief Medical ... | Buy | M | 0.00 | 5,000 | 0 | 39,485 | 34.5 K to 39.5 K (+14.50 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Baroldi Paolo | SVP & Chief Medical ... | Buy | M | 0.00 | 12,500 | 0 | 34,485 | 22 K to 34.5 K (+56.86 %) |
| Mar 10 2015 | VNDA | Vanda Pharmaceutic ... | DUGAN RICHARD W | Director | Option Exercise | M | 4.73 | 10,574 | 50,015 | 0 | |
| Mar 10 2015 | VNDA | Vanda Pharmaceutic ... | DUGAN RICHARD W | Director | Sell | S | 10.69 | 4,804 | 51,335 | 5,770 | 10.6 K to 5.8 K (-45.43 %) |
| Mar 10 2015 | VNDA | Vanda Pharmaceutic ... | DUGAN RICHARD W | Director | Buy | M | 4.73 | 10,574 | 50,046 | 10,574 | 0 to 10.6 K |